Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOSUNETUZUMAB-AXGB vs MYCOPHENOLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOSUNETUZUMAB-AXGB vs MYCOPHENOLATE: Safety Overview

Metric MOSUNETUZUMAB-AXGB MYCOPHENOLATE
Total FAERS Reports 198 7,807
Deaths Reported 13 1,159
Death Rate 6.6% 14.8%
Hospitalizations 48 2,802
Average Patient Age 63.5 yrs 49.0 yrs
% Female Patients 56.1% 44.7%
FDA Approval Date N/A Aug 19, 2014
Manufacturer N/A TWi Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription